SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16360450
Source:
http://linkedlifedata.com/resource/pubmed/id/16360450
Search
Subject
(
46
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0007600
,
umls-concept:C0059865
,
umls-concept:C0086418
,
umls-concept:C0334227
,
umls-concept:C0376358
,
umls-concept:C1280500
,
umls-concept:C1515655
,
umls-concept:C1533691
,
umls-concept:C1999216
pubmed:issue
6
pubmed:dateCreated
2005-12-19
pubmed:abstractText
To investigate the effects of the selective cyclooxygenase-2 (COX-2) inhibitor etodolac on prostate cancer cell lines in vitro and in vivo and on E-cadherin expression in prostate cancer cells.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0366151
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2 Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Etodolac
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1527-9995
pubmed:author
pubmed-author:FujisawaMasatoM
,
pubmed-author:GotohAkinobuA
,
pubmed-author:KamidonoSadaoS
,
pubmed-author:ShigemuraKatsumiK
,
pubmed-author:ShirakawaToshiroT
,
pubmed-author:WadaYoshitakaY
pubmed:issnType
Electronic
pubmed:volume
66
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1239-44
pubmed:meshHeading
pubmed-meshheading:16360450-Animals
,
pubmed-meshheading:16360450-Cell Division
,
pubmed-meshheading:16360450-Cyclooxygenase 2 Inhibitors
,
pubmed-meshheading:16360450-Etodolac
,
pubmed-meshheading:16360450-Humans
,
pubmed-meshheading:16360450-Male
,
pubmed-meshheading:16360450-Mice
,
pubmed-meshheading:16360450-Mice, Nude
,
pubmed-meshheading:16360450-Prostatic Neoplasms
,
pubmed-meshheading:16360450-Tumor Cells, Cultured
pubmed:year
2005
pubmed:articleTitle
Antitumor effects of etodolac, a selective cyclooxygenase-II inhibitor, against human prostate cancer cell lines in vitro and in vivo.
pubmed:affiliation
Division of Urology, Department of Organ Therapeutics, Faculty of Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
pubmed:publicationType
Journal Article